Heart failure with targeted cancer therapies: mechanisms and cardioprotection
VS Hahn, KW Zhang, L Sun, V Narayan… - Circulation …, 2021 - Am Heart Assoc
Oncology has seen growing use of newly developed targeted therapies. Although this has
resulted in dramatic improvements in progression-free and overall survival, challenges in …
resulted in dramatic improvements in progression-free and overall survival, challenges in …
Heart Failure With Targeted Cancer Therapies: Mechanisms and Cardioprotection.
VS Hahn, KW Zhang, L Sun, V Narayan… - Circulation …, 2021 - europepmc.org
Over the past two decades, oncology has seen growing use of newly developed targeted
therapies, with less emphasis on traditional chemotherapy based regimens. Although this …
therapies, with less emphasis on traditional chemotherapy based regimens. Although this …
Heart Failure with Targeted Cancer Therapies: Mechanisms and Cardioprotection
VS Hahn, KW Zhang, L Sun, V Narayan… - Circulation …, 2021 - pure.johnshopkins.edu
Oncology has seen growing use of newly developed targeted therapies. Although this has
resulted in dramatic improvements in progression-free and overall survival, challenges in …
resulted in dramatic improvements in progression-free and overall survival, challenges in …
Heart Failure with Targeted Cancer Therapies: Mechanisms and Cardioprotection
VS Hahn, KW Zhang, L Sun… - Circulation …, 2021 - utsouthwestern.elsevierpure.com
Oncology has seen growing use of newly developed targeted therapies. Although this has
resulted in dramatic improvements in progression-free and overall survival, challenges in …
resulted in dramatic improvements in progression-free and overall survival, challenges in …
[HTML][HTML] Heart Failure with Targeted Cancer Therapies: Mechanisms and Cardioprotection
VS Hahn, K Zhang, L Sun, V Narayan… - Circulation …, 2021 - ncbi.nlm.nih.gov
Over the past two decades, oncology has seen growing use of newly developed targeted
therapies, with less emphasis on traditional chemotherapy based regimens. Although this …
therapies, with less emphasis on traditional chemotherapy based regimens. Although this …
Heart Failure With Targeted Cancer Therapies: Mechanisms and Cardioprotection
VS Hahn, KW Zhang, L Sun, V Narayan… - Circulation …, 2021 - ingentaconnect.com
Oncology has seen growing use of newly developed targeted therapies. Although this has
resulted in dramatic improvements in progression-free and overall survival, challenges in …
resulted in dramatic improvements in progression-free and overall survival, challenges in …
Heart Failure With Targeted Cancer Therapies: Mechanisms and Cardioprotection
VS Hahn, KW Zhang, L Sun, V Narayan… - Circulation …, 2021 - pubmed.ncbi.nlm.nih.gov
Oncology has seen growing use of newly developed targeted therapies. Although this has
resulted in dramatic improvements in progression-free and overall survival, challenges in …
resulted in dramatic improvements in progression-free and overall survival, challenges in …
Heart Failure with Targeted Cancer Therapies: Mechanisms and Cardioprotection
VS Hahn, KW Zhang, L Sun, V Narayan… - Circulation …, 2021 - profiles.wustl.edu
Oncology has seen growing use of newly developed targeted therapies. Although this has
resulted in dramatic improvements in progression-free and overall survival, challenges in …
resulted in dramatic improvements in progression-free and overall survival, challenges in …
Heart Failure With Targeted Cancer Therapies
VS Hahn, KW Zhang, L Sun, V Narayan… - Circulation …, 2021 - cir.nii.ac.jp
抄録< jats: p> Oncology has seen growing use of newly developed targeted therapies.
Although this has resulted in dramatic improvements in progression-free and overall …
Although this has resulted in dramatic improvements in progression-free and overall …